+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Biological Valve Market by Tissue Material (Homograft, Xenograft), Implantation Method (Surgical, Transcatheter), Valve Position, End User - Global Forecast 2025-2030- Product Image
Artificial Biological Valve Market by Tissue Material (Homograft, Xenograft), Implantation Method (Surgical, Transcatheter), Valve Position, End User - Global Forecast 2025-2030- Product Image
New

Artificial Biological Valve Market by Tissue Material (Homograft, Xenograft), Implantation Method (Surgical, Transcatheter), Valve Position, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6116933
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The concept of an artificial biological valve has evolved from a niche experimental intervention to a pivotal element in modern cardiac care, blending engineering ingenuity with the intricate demands of human physiology. Over recent decades, advances in biomaterials, tissue processing, and surgical techniques have converged to elevate patient outcomes, reduce recovery times, and extend device longevity beyond early expectations. This introduction traces the journey of these valves from early prototypes to sophisticated implants capable of mimicking native valve function under dynamic hemodynamic conditions.

Emerging patient demographics, including aging populations and rising incidences of valvular heart diseases, have intensified the need for reliable solutions that minimize complications and improve quality of life. Innovations such as decellularized grafts and transcatheter delivery systems have gained traction, underscoring a shift toward less invasive approaches and biologically compatible materials. As we embark on a deeper exploration of market dynamics, this overview sets the stage for understanding how technological breakthroughs, regulatory shifts, and stakeholder partnerships collectively shape the trajectory of artificial biological valve adoption worldwide.

Mapping the Pivotal Technological, Clinical, and Regulatory Shifts That Are Redefining the Global Artificial Biological Valve Market Dynamics

The landscape of artificial biological valves is experiencing transformative shifts driven by breakthroughs in biomaterial engineering, regulatory harmonization, and evolving clinical protocols that are reshaping how valves are designed, tested, and deployed. On the technological front, three-dimensional printing and advanced decellularization techniques are enabling the creation of patient-specific grafts, reducing the likelihood of immune response and improving long-term functionality. Concurrently, the maturation of imaging modalities such as intravascular ultrasound and real-time MRI guidance is refining implantation accuracy, thereby reducing complications and accelerating patient recovery.

Regulatory frameworks in key markets are also evolving to facilitate faster approval pathways for devices demonstrating robust safety and efficacy profiles, while maintaining stringent post-market surveillance. This collaborative approach between regulatory bodies, clinical researchers, and device manufacturers is fostering a more agile environment for innovation. Meanwhile, the global rise in minimally invasive and transcatheter procedures is altering clinical guidelines, encouraging multidisciplinary teams to update protocols in response to improved patient outcomes and reduced hospital stays. Together, these shifts are propelling artificial biological valves toward a future where personalized medicine and streamlined regulatory processes drive sustainable growth and broader patient access.

Analyzing the Ripple Effects of the 2025 United States Tariffs on Supply Chains, Pricing Strategies, and Industry Competitiveness in Cardiac Valve Markets

The introduction of new tariff schedules by the United States in 2025 has created a complex set of challenges and opportunities for stakeholders in the artificial biological valve market. Import duties on key raw materials, including bovine and porcine tissues used for xenograft production, have prompted device manufacturers to reassess sourcing strategies. These adjustments have driven a reconfiguration of supply chains, with some organizations exploring nearshoring alliances or diversifying supplier portfolios to mitigate cost volatility and ensure uninterrupted access to critical biomaterials.

In parallel, the tariff-driven cost pressures have spurred heightened collaboration between manufacturers and contract research organizations to streamline production processes and achieve economies of scale. Negotiated agreements with tissue suppliers now focus on value-based contracting, incentivizing quality improvements and long-term partnerships. On the distribution front, companies are recalibrating pricing models-balancing the need to absorb portions of increased duties while safeguarding affordability for hospitals and ambulatory centers. Regulatory engagement has intensified as industry associations advocate for tariff exemptions on life-saving medical components, underlining the broader impact of trade policy on patient access and clinical outcomes.

Decoding Market Patterns Across Tissue Materials, Implantation Approaches, Valve Positions, and End User Settings to Unlock Strategic Growth Opportunities

Segmentation analysis reveals nuanced patterns in adoption and performance across distinct categories of artificial biological valves. Based on tissue material, homograft options that leverage cryopreserved or decellularized human tissue tend to exhibit strong acceptance within complex clinical scenarios requiring immunocompatibility, whereas xenograft variants, drawn from bovine and porcine sources, have gained traction for their scalable manufacturing and consistent supply profiles. Implantation method segmentation further highlights divergent pathways: surgical interventions span minimally invasive techniques that reduce hospital stays alongside open replacement procedures, while transcatheter approaches leverage transaortic, transapical, and transfemoral access points to extend treatment to patients deemed high risk for conventional surgery.

Valve position segmentation underscores that aortic implants constitute the primary focus due to prevalence of aortic stenosis, yet mitral, pulmonary, and tricuspid positions are attracting increasing research investment as clinicians seek solutions for complex multivalvular disease. Finally, end users range from ambulatory surgery centers emphasizing rapid throughput, to large hospital networks equipped for intensive care follow-up, and specialized clinics that deliver highly tailored patient interventions. Recognizing these segmentation nuances is essential to aligning product development roadmaps and marketing strategies with the distinct needs and growth drivers within each category.

Unearthing Regional Variations in Demand, Innovation Adoption, and Healthcare Infrastructure across Americas, EMEA, and Asia-Pacific

Regional analysis of artificial biological valve adoption illuminates diverse trajectories shaped by healthcare infrastructure, regulatory environments, and demographic pressure points. In the Americas, established reimbursement frameworks and high procedural volumes in aortic valve replacements drive ongoing investment in both surgical and transcatheter platforms. Conversely, markets in Latin America are characterized by initiatives to expand access through public-private partnerships and localized manufacturing models, responding to budget constraints without compromising clinical standards.

Europe, Middle East & Africa presents a heterogeneous picture: Western European markets maintain robust R&D pipelines and early adoption of decellularized grafts, while emerging markets within the region focus on scaling basic surgical capacity and training initiatives. Regulatory alignment under CE marking has streamlined device approvals, yet disparities in healthcare spending influence the pace of adoption. In Asia-Pacific, rapid urbanization and rising disposable incomes are fueling demand for minimally invasive alternatives. Regional leaders are investing in domestic production capabilities to reduce imports, while cross-border clinical collaborations are accelerating technology transfer and capacity building. Understanding these regional nuances is vital for tailoring market entry strategies and prioritizing resource allocation to areas with the greatest growth potential.

Profiling Leading Industry Players and Emerging Innovators Shaping the Future of Artificial Biological Valve Technology

A competitive overview of leading companies and emerging challengers underscores fierce rivalry in product development, strategic alliances, and clinical validation. Established medtech giants continue to invest heavily in next-generation valve designs, leveraging proprietary decellularization protocols and refined delivery systems to differentiate their portfolios. Meanwhile, mid-tier innovators are forging partnerships with academic institutions and contract development organizations to accelerate pipeline advancement and reduce time to market. The convergence of device manufacturers and digital health platforms has opened new avenues for remote monitoring and post-procedural data analytics, enhancing value propositions for healthcare providers.

Smaller specialized firms are also making notable contributions by focusing on niche segments such as pediatric valve replacement and biodegradable scaffold technologies, carving out defensible positions through agility and targeted clinical evidence. Strategic mergers and acquisitions have emerged as a key mechanism for securing technology platforms and expanding geographic reach, while collaborations with leading cardiovascular research centers serve to validate novel approaches under real-world conditions. This dynamic competitive environment compels all stakeholders to continuously refine their scientific, regulatory, and go-to-market strategies to capture emerging opportunities in both developed and emerging markets.

Strategic Imperatives and Actionable Recommendations for Industry Leaders to Capitalize on Emerging Opportunities in Artificial Biological Valve Market

To thrive in an increasingly complex marketplace, industry leaders must adopt a multi-faceted strategic playbook. First, investing in advanced decellularization and customized scaffold technologies can yield significant competitive advantages by enhancing biocompatibility and reducing immune-mediated complications. Second, forging deeper collaborations with tissue banks and contract research organizations will help secure critical material supplies and accelerate clinical evaluation timelines. Third, enhancing supply chain resilience by diversifying supplier geographies and incorporating nearshoring options will mitigate exposure to trade policy disruptions.

Furthermore, companies should leverage digital health platforms for remote patient monitoring and predictive maintenance of implanted valves, fostering long-term engagement and generating real-world evidence to support regulatory filings. Geographic expansion into underserved regions should be underpinned by tailored financing and training models that address local clinical and budgetary constraints. Finally, proactive engagement with regulatory agencies to shape evolving approval pathways can both expedite access and create de facto standards for safety and performance, positioning early adopters as industry benchmarks.

Outlining the Rigorous Research Methodology and Analytical Framework Underpinning the Artificial Biological Valve Market Analysis

This analysis is grounded in a rigorous research methodology designed to ensure accuracy, relevance, and comprehensiveness. Primary research involved in-depth interviews with cardiothoracic surgeons, biomedical engineers, hospital procurement leaders, and regulatory experts to capture real-world perspectives on technological trends, clinical outcomes, and adoption barriers. Secondary research encompassed a thorough review of peer-reviewed journals, regulatory filings, patent databases, and industry conferences to validate key findings and identify emerging innovations.

Quantitative data synthesis employed data triangulation techniques, cross-referencing insights from proprietary databases, clinical registries, and industry reports. Qualitative analysis included thematic coding of interview transcripts to distill strategic imperatives and market dynamics. Segmentation frameworks were developed based on tissue material, implantation method, valve position, and end user categories, ensuring that growth drivers and challenges were contextualized within each segment. Finally, all insights underwent a multi-layered validation process involving expert review to confirm factual integrity and applicability to decision-making scenarios.

Concluding Perspectives on Market Evolution, Strategic Imperatives, and the Path Forward for Artificial Biological Valve Solutions

In conclusion, the artificial biological valve sector stands at the intersection of biomedical innovation, evolving clinical paradigms, and dynamic geopolitical influences. The interplay between advanced tissue processing methods, minimally invasive delivery techniques, and regulatory harmonization is charting a path toward more personalized and durable solutions for patients worldwide. Tariff-induced supply chain realignments underscore the importance of strategic sourcing and diversified partnerships, while segmented demand patterns highlight the need for tailored approaches across material types, procedural methods, anatomical positions, and care settings.

Regional disparities in infrastructure and adoption rates present both challenges and growth pockets, necessitating nuanced market entry strategies. The competitive landscape is defined by continuous investment in R&D, digital integration, and strategic collaborations, compelling industry leaders to remain agile and forward-looking. By integrating the actionable recommendations outlined earlier-spanning technological investment, supply chain optimization, digital engagement, and regulatory advocacy-stakeholders can effectively navigate the evolving market terrain and position themselves for sustainable success in this transformational medical device arena.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Tissue Material
    • Homograft
      • Cryopreserved
      • Decellularized
    • Xenograft
      • Bovine
      • Porcine
  • Implantation Method
    • Surgical
      • Minimally Invasive
      • Open Replacement
    • Transcatheter
      • Transaortic
      • Transapical
      • Transfemoral
  • Valve Position
    • Aortic
    • Mitral
    • Pulmonary
    • Tricuspid
  • End User
    • Ambulatory Surgery Centers
    • Hospitals
    • Specialized Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • CryoLife, Inc.
  • JenaValve Technology, Inc.
  • Hangzhou Venus MedTech Co., Ltd.
  • 4C Medical Technologies, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising integration of transcatheter bioprosthetic valve procedures for high-risk cardiovascular patients
5.2. Development of next-generation bovine pericardial valves with novel anti-calcification surface treatments
5.3. Expansion of 3D printing technologies for customizing patient-specific biological heart valve implants
5.4. Increased focus on polymer-based scaffold structures to improve long-term valve performance and biocompatibility
5.5. Strategic partnerships between medical device companies and research institutes to accelerate valve innovation timelines
5.6. Growing regulatory approvals of next-generation valves with enhanced hemodynamics and reduced thrombogenic profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Biological Valve Market, by Tissue Material
8.1. Introduction
8.2. Homograft
8.2.1. Cryopreserved
8.2.2. Decellularized
8.3. Xenograft
8.3.1. Bovine
8.3.2. Porcine
9. Artificial Biological Valve Market, by Implantation Method
9.1. Introduction
9.2. Surgical
9.2.1. Minimally Invasive
9.2.2. Open Replacement
9.3. Transcatheter
9.3.1. Transaortic
9.3.2. Transapical
9.3.3. Transfemoral
10. Artificial Biological Valve Market, by Valve Position
10.1. Introduction
10.2. Aortic
10.3. Mitral
10.4. Pulmonary
10.5. Tricuspid
11. Artificial Biological Valve Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Hospitals
11.4. Specialized Clinics
12. Americas Artificial Biological Valve Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Artificial Biological Valve Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Artificial Biological Valve Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Edwards Lifesciences Corporation
15.3.2. Medtronic plc
15.3.3. Abbott Laboratories
15.3.4. Boston Scientific Corporation
15.3.5. LivaNova PLC
15.3.6. MicroPort Scientific Corporation
15.3.7. CryoLife, Inc.
15.3.8. JenaValve Technology, Inc.
15.3.9. Hangzhou Venus MedTech Co., Ltd.
15.3.10. 4C Medical Technologies, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ARTIFICIAL BIOLOGICAL VALVE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ARTIFICIAL BIOLOGICAL VALVE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ARTIFICIAL BIOLOGICAL VALVE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHAI
FIGURE 24. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHSTATISTICS
FIGURE 25. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHCONTACTS
FIGURE 26. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ARTIFICIAL BIOLOGICAL VALVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY DECELLULARIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY DECELLULARIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY BOVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PORCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY OPEN REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY OPEN REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAORTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAORTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AORTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MITRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MITRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PULMONARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PULMONARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRICUSPID, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 102. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 103. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 104. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 105. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 106. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 107. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 108. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 109. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 110. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 111. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 112. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 113. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 114. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 115. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 200. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 201. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 202. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 203. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 204. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 218. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 219. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 220. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 248. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 249. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 250. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 251. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 252. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 253. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 254. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 255. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 256. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 257. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 258. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 259. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 260. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 261. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 264. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 266. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 267. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 268. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Artificial Biological Valve market report include:
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • CryoLife, Inc.
  • JenaValve Technology, Inc.
  • Hangzhou Venus MedTech Co., Ltd.
  • 4C Medical Technologies, Inc.

Related Topics

Related Reports

Bioprosthetics Market by Product Type (Cardiovascular Grafts, Dental Prostheses, Dermal Substitutes), Material Type (Biological Material, Synthetic Material), Application, End User - Global Forecast 2025-2030 - Product Image

Bioprosthetics Market by Product Type (Cardiovascular Grafts, Dental Prostheses, Dermal Substitutes), Material Type (Biological Material, Synthetic Material), Application, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Biological Implants Market by Orthopedic Implants (Joint Replacement, Osteosynthesis, Trauma Fixation), Cardiovascular Implants (Heart Valves, Stents, Vascular Grafts), Dental Implants, Spinal Implants, Neurological Implants, Ocular Implants - Global Forecast 2025-2030 - Product Image

Biological Implants Market by Orthopedic Implants (Joint Replacement, Osteosynthesis, Trauma Fixation), Cardiovascular Implants (Heart Valves, Stents, Vascular Grafts), Dental Implants, Spinal Implants, Neurological Implants, Ocular Implants - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Biological Implants - Global Strategic Business Report - Product Image

Biological Implants - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Cardiac Tissue Engineering Market Size, Share & Trends by Material (Scaffold, Stem Cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-user (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029 - Product Image

Cardiac Tissue Engineering Market Size, Share & Trends by Material (Scaffold, Stem Cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-user (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029

  • Report
  • 337 Pages
  • Global
From
Cryogenic Valves - Global Strategic Business Report - Product Image

Cryogenic Valves - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.